Association between PADI4 gene polymorphisms and anti-cyclic citrullinated peptide antibody positive rheumatoid arthritis in a large Chinese Han cohort

Clinical and Experimental Rheumatology

Volumn 32, Issue 3, 2014, Pages 1-6

  Du, Yan ^a   Liu, Xu ^a   Guo, Jian Ping ^a   Liu, Xia ^a,c   Li, Ru ^a   Zhao, Yi ^b   Li, Ming Hui ^a   Li, Zhan Guo ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Anti cyclic citrullinated peptide antibody; Bone destruction; Peptidyl arginine deiminase type IV; Rheumatoid arthritis; Single nucleotide polymorphism

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; HYDROLASE; PEPTIDYLARGININE DEIMINASE TYPE IV;

ADULT; ARTICLE; BONE DESTRUCTION; CHINESE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; JOINT RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PADI4 GENE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN; BLOOD; COHORT ANALYSIS; EPIDEMIOLOGY; ETHNOLOGY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETICS; IMMUNOLOGY; MIDDLE AGED; PHENOTYPE; RISK FACTOR; STATISTICS;

ADULT; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; COHORT STUDIES; FEMALE; GENE FREQUENCY; HUMANS; HYDROLASES; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 84901827968     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. MacGREGOR AJ, SNIEDER H, RIGBY AS et al.: Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000; 43: 30-7.
2. SELDIN MF, AMOS CI, WARD R, GREGERSEN PK: The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 1999; 42: 1071-9.
3. SILMAN AJ, MacGREGOR AJ, THOMSON W et al.: Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 1993; 32: 903-7.
4. STASTNY P: Association of the B-cell allo- antigen DRw4 with rheumatoid arthritis. N Engl J Med 1978; 298: 869-71.
5. PLENGE RM: Recent progress in rheumatoid arthritis genetics: one step towards improved patient care. Curr Opin Rheumatol 2009; 21: 262-71.
6. IWAMOTO T, IKARI K, NAKAMURA T et al.: Association between PADI4 and rheumatoid arthritis: a meta-analysis. Rheumatology (Oxford) 2006; 45: 804-7.
7. KANG CP, LEE HS, JU H, CHO H, KANG C, BAE SC: A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum 2006; 54: 90-6.
8. FAN LY, ZONG M, LU TB, YANG L, DING YY, MA JW: [Association of the PADI4 gene po-lymorphism and HLA-DRB1 shared epitope alleles with rheumatoid arthritis]. Article in Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2009; 26: 57-61.
9. GANDJBAKHCH F, FAJARDY I, FERRE B et al.: A functional haplotype of PADI4 gene in rheumatoid arthritis: positive correlation in a French population. J Rheumatol 2009; 36: 881-6.
10. HOPPE B, HAUPL T, GRUBER R et al.: Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study. Arthritis Res Ther 2006; 8: R34.
11. ABD-ALLAH SH, el-SHAL AS, SHALABY SM et al.: PADI4 polymorphisms and related haplotype in rheumatoid arthritis patients. Joint Bone Spine 2012; 79: 124-8.
12. CHEN R, WEI Y, CAI Q et al.: The PADI4 gene does not contribute to genetic susceptibility to rheumatoid arthritis in Chinese Han population. Rheumatology Int 2011; 31: 1631-4.
13. CHENG J, ZHANG H, ZHUANG C, LIU R: Peptidylarginine deiminase type 4 and methyl-CpG binding domain 4 polymorphisms in Chinese patients with rheumatoid arthritis. J Rheumatol 2012; 39: 1159-65.
14. SUZUKI A, YAMADA R, CHANG X et al.: Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003; 34: 395-402.
15. KLARESKOG L, RONNELID J, LUNDBERG K, PADYUKOV L, ALFREDSSON L: Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol 2008; 26: 651-75.
16. KOCHI Y, SUZUKI A, YAMADA R, YAMA-MOTO K: Genetics of rheumatoid arthritis: underlying evidence of ethnic differences. J Autoimmun 2009; 32: 158-62.
17. CHA S, CHOI CB, HAN TU, KANG CP, KANG C, BAE SC: Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis. Arthritis Rheum 2007; 56: 1454-63.
18. HOPPE B, HAUPL T, EGERER K et al.: Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis. Ann Rheum Dis 2009; 68: 898-903.
19. SUZUKI T, IKARI K, YANO K et al.: PADI4 and HLA-DRB1 are genetic risks for radiographic progression in RA patients, independent of ACPA status: results from the IORRA cohort study. PloS One 2013; 8: e61045.
20. BANG SY, HAN TU, CHOI CB, SUNG YK, BAE SC, KANG C: Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study. Arthritis Res Ther 2010; 12: R115.
21. TOO CL, MURAD S, DHALIWAL JS et al.: Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis. Arthritis Res Ther 2012; 14: R250.
22. BURR ML, NASEEM H, HINKS A et al.: PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population. Ann Rheum Dis 2010; 69: 666-70.
23. IKARI K, KUWAHARA M, NAKAMURA T et al.: Association between PADI4 and rheumatoid arthritis: a replication study. Arthritis Rheum 2005; 52: 3054-7.
24. BARTON A, BOWES J, EYRE S et al.: A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum 2004; 50: 1117-21.
25. SUZUKI M, MIYAGI J, KURIBAYASHI M, NEGISHI E, UENO K, MORIYA H: Evaluation of allele frequencies in the PADI4 gene and anti-cyclic citrullinated peptide antibodies of patients with rheumatoid arthritis in a Japanese population. Ann Rheum Dis 2006; 65: 1399-400.
26. MARTINEZ A, VALDIVIA A, PASCUAL-SALCEDO D et al.: PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population. Rheumatology (Oxford) 2005; 44: 1263-6.
27. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
28. van der HEIJDE D: How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 2000; 27: 261-3.
29. ZHAO J, ZHAO Y, HE J, JIA R, LI Z: Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis. J Rheumatol 2008; 35: 969-74.
30. KEENE ON: The log transformation is special. Stat Med 1995; 14: 811-9.
31. HARRIS ML, DARRAH E, LAM GK et al.: Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis. Arthritis Rheum 2008; 58: 1958-67.